| 1 |
Gao H, Song Y, Liu K, et al. The impact of different smoking behavior on pulmonary function and pulmonary hypertension among Chinese male patients with chronic obstructive pulmonary disease[J]. Int J Chron Obstruct Pulmon Dis, 2024, 19, 1315- 1331.
doi: 10.2147/COPD.S455323
|
| 2 |
Balistrieri A, Makino A, Yuan JX. Pathophysiology and pathogenic mechanisms of pulmonary hypertension: role of membrane receptors, ion channels, and Ca2+ signaling[J]. Physiol Rev, 2023, 103 (3): 1827- 1897.
doi: 10.1152/physrev.00030.2021
|
| 3 |
Andreu-Martínez R, Munar-Rubert O, Rodríguez-Pérez J, et al. Uncovering a novel role of nAChRs in oxidative stress-mediated vascular dysfunction in COPD[J]. Redox Biol, 2025, 86, 103838.
doi: 10.1016/j.redox.2025.103838
|
| 4 |
Sevilla-Montero J, Labrousse-Arias D, Fernández-Pérez C, et al. Cigarette smoke directly promotes pulmonary arterial remodeling and Kv7.4 channel dysfunction[J]. Am J Respir Crit Care Med, 2021, 203 (10): 1290- 1305.
doi: 10.1164/rccm.201911-2238OC
|
| 5 |
Roxlau ET, Pak O, Hadzic S, et al. Nicotine promotes e-cigarette vapour-induced lung inflammation and structural alterations[J]. Eur Respir J, 2023, 61 (6): 2200951.
doi: 10.1183/13993003.00951-2022
|
| 6 |
Fried ND, Morris TM, Whitehead A, et al. Angiotensin II type 1 receptor mediates pulmonary hypertension and right ventricular remodeling induced by inhaled nicotine[J]. Am J Physiol Heart Circ Physiol, 2021, 320 (4): H1526- H1534.
doi: 10.1152/ajpheart.00883.2020
|
| 7 |
Jackson WF. Potassium channels in regulation of vascular smooth muscle contraction and growth[J]. Adv Pharmacol, 2017, 78, 89- 144.
doi: 10.1016/bs.apha.2016.07.001
|
| 8 |
Redel-Traub G, Sampson KJ, Kass RS, et al. Potassium channels as therapeutic targets in pulmonary arterial hypertension[J]. Biomolecules, 2022, 12 (10): 1386.
|
| 9 |
Whitehead AK, Erwin AP, Yue X. Nicotine and vascular dysfunction[J]. Acta Physiol (Oxf), 2021, 231 (4): e13631.
doi: 10.1111/apha.13631
|
| 10 |
Al-Chawishly M, Loveland O, Gurney AM. Kv7 channels in cyclic-nucleotide dependent relaxation of rat intra-pulmonary artery[J]. Cells, 2022, 12 (3): 429.
doi: 10.3390/biom12030429
|
| 11 |
Mondéjar-Parreño G, Barreira B, Callejo M, et al. Uncovered contribution of Kv7 channels to pulmonary vascular tone in pulmonary arterial hypertension[J]. Hypertension, 2020, 76 (4): 1134- 1146.
doi: 10.1161/HYPERTENSIONAHA.120.15221
|
| 12 |
张珂瑜, 侯晓敏, 邹佳佳, 等. 杜鹃素通过激活Kv通道舒张C57BL/6J小鼠离体肺动脉[J]. 中国临床药理学与治疗学, 2021, 33 (3): 202- 208.
doi: 10.20039/j.cnki.1007-3949.2025.03.003
|
| 13 |
Yang R, Liu Y, Hou X, et al. MAPKs-mediated modulation of the myocyte voltage-gated K+ channels is involved in ethanol-induced rat coronary arterial contraction[J]. Eur J Pharmacol, 2018, 834, 274- 280.
doi: 10.1016/j.ejphar.2018.07.042
|
| 14 |
Petsophonsakul P, Burgmaier M, Willems B, et al. Nicotine promotes vascular calcification via intracellular Ca2+-mediated, Nox5-induced oxidative stress, and extracellular vesicle release in vascular smooth muscle cells[J]. Cardiovasc Res, 2022, 118 (9): 2196- 2210.
doi: 10.1093/cvr/cvab244
|
| 15 |
Singhrao N, Flores-Tamez VA, Moustafa YA, et al. Nicotine impairs smooth muscle cAMP signaling and vascular reactivity[J]. Microcirculation, 2024, 31 (6): e12871.
doi: 10.1111/micc.12871
|
| 16 |
Yeung SY, Greenwood IA. Electrophysiological and functional effects of the KCNQ channel blocker XE991 on murine portal vein smooth muscle cells[J]. Br J Pharmacol, 2005, 146 (4): 585- 595.
doi: 10.1038/sj.bjp.0706342
|
| 17 |
Bousseau S, Sobrano-Fais R, Gu S, et al. Pathophysiology and new advances in pulmonary hypertension[J]. BMJ Med, 2023, 2 (1): e000137.
doi: 10.1136/bmjmed-2022-000137
|
| 18 |
秦小江, 许欣荣, 杜旭峰, 等. 慢性尼古丁干预抑制Kv1.5致小鼠肺动脉舒缩异常的机制研究[J]. 毒理学杂志, 2021, 35 (6): 439- 444.
doi: 10.16421/j.cnki.1002-3127.2021.06.001
|
| 19 |
赵旭, 侯晓敏, 孙琳, 等. 尼古丁上调Cx43促发PASMCs炎性反应致小鼠肺动脉重构的机制[J]. 环境卫生学杂志, 2024, 14 (9): 780- 787.
doi: 10.13421/j.cnki.hjwsxzz.2024.09.010
|
| 20 |
Pereira da Silva EA, Martín-Aragón Baudel M, Navedo MF, et al. Lon channel molecular complexes in vascular smooth muscle[J]. Front Physiol, 2022, 13, 865239.
|
| 21 |
Climént B, Vera-Zambrano A, Barreira B, et al. The novel Kv7 channel activator URO-K10 exerts enhanced pulmonary vascular effects independent of the KCNE4 regulatory subunit[J]. Biomed Pharmacother, 2023, 164, 114952.
doi: 10.1016/j.biopha.2023.114952
|